. . . . . . . "[a carrier of the founder CDKN2A [p.Leu113Leu; p.Pro114Ser]mutation as well as two MC1R moderate-risk variants, [p.Arg151Cys (+) p.Arg163Gln]developed 22 primary melanomas in the 3 years that followed initiation of levodopa therapy for Parkinson's disease]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en . . . . . "2009-03-31"^^ . . "Gene-disease associations inferred from text-mining the literature."@en . "DisGeNET evidence - LITERATURE"@en . "2017-10-17T13:11:27+02:00"^^ . . . . . . . . . . . "v5.0.0.0" . "v5.0.0" .